AMRI Announces Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Albany Molecular Research (AMRI) Tops Q2 EPS by 4c
August 4, 2015 7:34 AM EDTAlbany Molecular Research (NASDAQ: AMRI) reported Q2 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $85.2 million versus the consensus estimate of $85 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
... More